| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |